InMed Pharmaceuticals Inc. (INM)
NASDAQ · Healthcare
InMed Pharmaceuticals Inc. Income Statement 2021–2025
| Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 | |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | 4.9M | 4.6M | 4.1M | 1.4M | 1.9M |
| Gross Profit | 1.7M | 1.1M | 1.4M | 543,546 | — |
| Profitability | |||||
| Operating Income | — | — | -7.9M | -18.6M | -10.2M |
| EBITDA | — | — | -7.7M | -18.4M | -10.1M |
| Net Income | -8.2M | -7.7M | -7.9M | -18.6M | -10.2M |
| Per Share Data | |||||
| EPS (diluted) | $-8.36 | $-20.14 | $-3.25 | $-33.17 | $-37.96 |
| Shares Outstanding (dil.) | 1M | 0M | 2M | 1M | 0M |
InMed Pharmaceuticals Inc. Income Statement — FAQ
InMed Pharmaceuticals Inc. (INM) income statement over the last 5 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INM's income statement history?
The chart and table above show InMed Pharmaceuticals Inc.'s income statement by year and by quarter, including the growth rate.